# Madrigal Pharmaceuticals, Inc.: Form 8-K, filed Feb 19, 2026

- Company: [Madrigal Pharmaceuticals, Inc.](/companies/mdgl.md) (CIK 1157601)
- Form: 8-K
- Filed: 2026-02-19
- Accepted by EDGAR: Feb 19, 2026, 07:05 ET
- Period: 2026-02-19
- Accession: 0001628280-26-009476
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1157601/000162828026009476/mdgl-20260219.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1157601/000162828026009476/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1157601/000162828026009476/mdgl-20260219.htm

Filed Feb 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-009476. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.